Cudarolimab (Anti-TNFRSF4 / OX40 / CD134)

Cudarolimab (Anti-TNFRSF4 / OX40 / CD134) is an agonistic fully human anti-OX40 (tumor necrosis factor receptor superfamily member 4, TNFRSF4, CD134, OX40L receptor) with potential immune checkpoint inhibitory and antineoplastic activities. MW : 145.94 KD.

• Supplier: Selleck Chemicals
• Product #: A2814
• Sku #: A2814-1mg